Richard S Levy is of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 14,200 shares of KNSA, which is worth approximately $283,148. The most recent transaction as insider was on Nov 07, 2024, when has been sold 1,303 shares (Class A Ordinary Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.2K
10.1% 3M change
82.59% 12M change
Total Value Held $283,148

Richard S Levy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2024
BUY
Exercise of conversion of derivative security
-
1,303 Added 8.4%
14,200 Class A Ordinary Share
Jun 06 2024
BUY
Exercise of conversion of derivative security
-
4,373 Added 25.32%
12,897 Class A Common Share
May 03 2024
BUY
Exercise of conversion of derivative security
-
747 Added 8.06%
8,524 Class A Common Share
Nov 03 2023
BUY
Exercise of conversion of derivative security
-
2,777 Added 26.31%
7,777 Class A Common Share
Jun 29 2023
BUY
Exercise of conversion of derivative security
-
5,000 Added 50.0%
5,000 Class A Common Share

Also insider at

CNST
CONSTELLATION PHARMACEUTICALS INC Healthcare
TARA
Protara Therapeutics, Inc. Healthcare
MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
KOD
Kodiak Sciences Inc. Healthcare
RSL

Richard S Levy

Palo Alto, CA

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA